Tyler Jacks - Thermo Fisher Independent Director

TMO Stock  USD 593.03  15.10  2.61%   

Director

Dr. Tyler Jacks, Ph.D. is Independent Director of the Company. He is the David H. Koch Professor of Biology at the Massachusetts Institute of Technology and director of the David H. Koch Institute for Integrative Cancer Research. He joined the MIT faculty in 1992 and was director of its Center for Cancer Research from 2001 to 2008. Since 2002, Dr. Jacks was an investigator with the Howard Hughes Medical Institute since 2020.
Age 59
Tenure 4 years
Professional MarksPh.D
Phone781 622 1000
Webhttps://www.thermofisher.com
Jacks is also a director of Amgen Inc. We believe that Dr. Jacks is well suited to serve on our Board due to his experience as a cancer researcher and member of multiple scientific advisory boards in biotechnology companies, pharmaceutical companies and academic institutions.

Thermo Fisher Management Efficiency

The company has Return on Asset of 0.0482 % which means that on every $100 spent on assets, it made $0.0482 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1362 %, implying that it generated $0.1362 on every 100 dollars invested. Thermo Fisher's management efficiency ratios could be used to measure how well Thermo Fisher manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 34.92 B in debt with debt to equity (D/E) ratio of 0.67, which is OK given its current industry classification. Thermo Fisher Scientific has a current ratio of 1.71, which is typical for the industry and considered as normal. Debt can assist Thermo Fisher until it has trouble settling it off, either with new capital or with free cash flow. So, Thermo Fisher's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Thermo Fisher Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Thermo to invest in growth at high rates of return. When we think about Thermo Fisher's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

JeanPaul MangeolleCharles River Laboratories
57
Walter LohrDanaher
77
Daniel PodolskyAgilent Technologies
67
Richard WallmanCharles River Laboratories
69
Virginia WilsonCharles River Laboratories
66
Francis deSouzaIllumina
53
Linda BaddourWaters
62
Michael KellyMettler Toledo International
64
George MilneCharles River Laboratories
77
A SandersDanaher
58
Dow WilsonAgilent Technologies
61
George ScangosAgilent Technologies
72
Teri ListStollDanaher
58
Martin MackayCharles River Laboratories
65
Caspar TudorWaters
N/A
Thomas SaliceMettler Toledo International
61
George LladoCharles River Laboratories
55
Richard ReeseCharles River Laboratories
75
Christopher KueblerWaters
66
Heidi KunzAgilent Technologies
66
Edward ConardWaters
63
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company was incorporated in 1956 and is based in Waltham, Massachusetts. Thermo Fisher operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 130000 people. Thermo Fisher Scientific (TMO) is traded on New York Stock Exchange in USA. It is located in 168 Third Avenue, Waltham, MA, United States, 02451 and employs 122,000 people. Thermo Fisher is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Thermo Fisher Scientific Leadership Team

Elected by the shareholders, the Thermo Fisher's board of directors comprises two types of representatives: Thermo Fisher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Thermo. The board's role is to monitor Thermo Fisher's management team and ensure that shareholders' interests are well served. Thermo Fisher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Thermo Fisher's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jim Manzi, Independent Chairman of the Board
Michel Lagarde, Senior Vice President and President, Pharma Services
Mark Stevenson, Executive VP and President of Life Sciences Solutions
Rafael Tejada, Vice Relations
Stephen Williamson, Chief Financial Officer, Senior Vice President
Tyler Jacks, Independent Director
James Mullen, Independent Director
Dion Weisler, Independent Director
Karen Nelson, Chief Officer
Debora Spar, Independent Director
Peter Hornstra, Vice President Chief Accounting Officer
Judy Lewent, Independent Director
Michael Boxer, Senior Vice President General Counsel
Ruby Chandy, Director
Joseph Holmes, Chief Accounting Officer, Vice President
Lars Sorensen, Independent Director
C Harris, Independent Director
Elaine Ullian, Independent Director
Thomas Lynch, Director, Chairman of Nominating and Corporate Governance Committee and Member of Compensation Committee
Ryan Snyder, Senior Officer
Nelson Chai, Independent Director
Syed Jafry, Senior Vice President and President Regions
Marc Casper, CEO and President Director, Member of Strategy and Fin. Committee and Member of Science and Technology Committee
Michael Esq, Senior Counsel
Sandy Pound, VP Officer
Scott Sperling, Independent Director
R Keith, Independent Director
Gianluca Pettiti, Senior Vice President and Presidentident - Specialty Diagnostics business

Thermo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Thermo Fisher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Thermo Fisher in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Thermo Fisher's short interest history, or implied volatility extrapolated from Thermo Fisher options trading.

Currently Active Assets on Macroaxis

When determining whether Thermo Fisher Scientific offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Thermo Fisher's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Thermo Fisher Scientific Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Thermo Fisher Scientific Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Thermo Stock analysis

When running Thermo Fisher's price analysis, check to measure Thermo Fisher's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Thermo Fisher is operating at the current time. Most of Thermo Fisher's value examination focuses on studying past and present price action to predict the probability of Thermo Fisher's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Thermo Fisher's price. Additionally, you may evaluate how the addition of Thermo Fisher to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Thermo Fisher's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.